$4.6 million grant will help Stratatech start clinical trials of skin substitute
Madison-based Stratatech Corp. is getting a $4.6 million grant to help fund the start of clinical trials of ExpressGraft, a skin substitute designed to heal diabetes-related foot ulcers. (WISCONSIN STATE JOURNAL, 11/1)
To access this content, you must purchase a Premium membership, or log in if you are a member.
